Adriamycin induced spermatogenesis defect is due to the reduction in epididymal adipose tissue mass: A possible hypothesis

Medical Hypotheses

Volumn 78, Issue 2, 2012, Pages 218-220

  Tirupathi Pichiah, P B ^a   Sankarganesh, A ^a   Kalaiselvi, S ^b   Indirani, K ^b   Kamalakkannan, S ^b   SankarGanesh, D ^b   Hwang, Pyoung Han ^a   Cha, Youn Soo ^a   Achiraman, S ^b  

^a Chonbuk National University   (South Korea)

^b BHARATHIDASAN UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; DOXORUBICIN; GLITAZONE DERIVATIVE; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THIOGLITAZONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; APOPTOSIS; ARTICLE; DOWN REGULATION; DRUG MECHANISM; EPIDIDYMAL WHITE ADIPOSE TISSUE; EPIDIDYMIS FAT; NONHUMAN; PROTEIN EXPRESSION; REPRODUCTIVE TOXICITY; SEMEN ABNORMALITY; SEMINAL VESICLE; SPERMATID; SPERMATOGENESIS; SPERMATOZOON MATURATION; TESTIS WEIGHT; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ADIPOSE TISSUE, WHITE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; EPIDIDYMIS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; PPAR GAMMA; REACTIVE OXYGEN SPECIES; SPERM COUNT; SPERMATOGENESIS;

ANIMALIA;

EID: 84855192482     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.10.027     Document Type: Article

References (26)

1. Blum R.H., Carter S.K. Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Med 1974, 80:249-259.
2. Tan C., Tasaka H., Yu K.P., Murphy M.L., Karnofsky D.A. Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia. Cancer 1967, 20:333-353.
3. Okuda S., Oh Y., Tsuruda H., Onoyama K., Fujimi S., Fujishima M. Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 1986, 29:502-510.
4. Al-Bekairi Abdullah M., Osman Abdel M.M., Hafeez Mohamed A., Al-Gharably Naji M., Al-Shabanah Othman A., Al-Harbi Mohamed M. Effect of desferrioxamine on the hepatotoxicity of adriamycin in normal mice. Drug Dev Res 1993, 29:56-62.
5. Herman E.H., Ferrans V.J. Animal models of anthracycline cardiotoxicity: basic mechanisms and cardioprotective activity. Prog Pediatr Cardiol 1997, 8:49-58.
6. Au W.W., Hsu T.C. The genotoxic effects of adriamycin in somatic and germinal cells of the mouse. Mutat Res 1980, 79:351-361.
7. Lui R.C., Laregina M.C., Herbold D.R., Johnson F.E. Testicular cytotoxicity of intravenous doxorubicin in rats. J Urol 1986, 136:940-943.
8. Goodman J., Hochstein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem Biophys Res Commun 1977, 77:797-803.
9. Ward J.A., Bardin C.W., Knight M., Robinson J., Gunsalus G., Morris I.D. Delayed effects of doxorubicin on spermatogenesis and endocrine function in rats. Reprod Toxicol 1988, 2:117-126.
10. Sjoblom T., West A., Lahdetie J. Apoptotic response of spermatogenic cells to the germ cell mutagens etoposide, adriamycin, and diepoxybutane. Environ Mol Mutagen 1998, 31:133-148.
11. Li Y., McClintick J., Zhong L., Edenberg H.J., Yoder M.C., Chan R.J. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 2005, 105:635-637.
12. Segre J.A., Bauer C., Fuchs E. Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 1999, 22:356-360.
13. Katz J.P., Perreault N., Goldstein B.G., Lee C.S., Labosky P.A., Yang V.W., et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002, 129:2619-2628.
14. Katz J.P., Perreault N., Goldstein B.G., Actman L., McNally S.R., Silberg D.G., et al. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology 2005, 128:935-945.
15. Nakatake Y., Fukui N., Iwamatsu Y., Masui S., Takahashi K., Yagi R., et al. Klf4 cooperates with Oct3/4 and Sox2 to activate the LEWATy1 core promoter in embryonic stem cells. Mol Cell Biol 2006, 26:7772-7782.
16. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
17. Behr R., Kaestner K.H. Developmental and cell type-specific expression of the zinc finger transcription factor Kruppel-like factor 4 (Klf4) in postnatal mouse testis. Mech Dev 2002, 115:167-169.
18. Godmann M., Kromberg I., Mayer J., Behr R. The mouse Kruppel-like factor 4 (Klf4) gene: four functional polyadenylation sites which are used in a cell-specific manner as revealed by testicular transcript analysis and multiple processed pseudogenes. Gene 2005, 36:149-156.
19. Jones J.R., Barrick C., Kim K.A., Lindner J., Blondeau B., Fujimoto Y., et al. Deletion of PPAR gamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 2005, 102:6207-6212.
20. Thomas K., Sung D.Y., Chen X., Thompson W., Chen Y.E., McCarrey J., et al. Developmental patterns of PPAR and RXR gene expression during spermatogenesis. Front Biosci (Elite Ed) 2011, 3:1209-1220.
21. Birsoy K., Chen Z., Friedman J. Transcriptional regulation of adipogenesis by KLF4. Cell Metab 2008, 7:339-347.
22. Tanaka T., Yoshida N., Kishimoto T., Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J 1997, 16:7432-7443.
23. Cao Z., Umek R.M., McKnight S.L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 1991, 5:1538-1552.
24. Yeh W.C., Cao Z., Classon M., McKnight S.L. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995, 9:168-181.
25. Chu Y., Huddleston G.G., Clancy A.N., Harris R.B., Bartness T.J. Epididymal fat is necessary for spermatogenesis, but not testosterone production or copulatory behavior. Endocrinology 2010, 151:5669-5679.
26. Zhou Q., Hong Y., Zhan Q., Shen Y., Liu Z. Role for Kurppel-like factor 4 in determining the outcome of p53 response to DNA damage. Cancer Res 2009, 69:8284-8292.